Glenmark Share Price Target 2025, 2027, 2030, 2040, and 2050

If you are wondering which share will be best for investment in recent times then you should know about Glenmark Share Price Target 2025, 2030, 2040, and 2050. Today in this article we will explain the basic idea about the Glenmark Share Price Target 2025, 2027, 2030, 2040, and 2050. Based on our research and expert advice, this blog is about the company’s growth, performance, etc.

In this article, we will describe the company’s financial growth, business policy, shareholding pattern, and forecast share price yearly. Glenmark Share Price Target is a trading share in the share market. We use expert research and analysis to understand the Glenmark Share Price Target. This article may be useful to those who want to invest in this share. Let’s explore the Glenmark Share Price Target from 2025 to 2050.

Introduction

Established in 1977, Glenmark Pharmaceutical Limited is a worldwide pharmaceutical company based in India. The corporation’s corporate office is located in Mumbai, India. The business was founded in 1977 as a producer of active pharmaceutical ingredients and generic medications. The company ships its goods to Russia, Africa, and India.

Overview

The company has recently concentrated on novel medications and biosimilars in the domains of dermatology, respiratory disorders, and cancer. The company’s research and development division created a medication in 2016 and licensed it to Japan and North America to treat COPD and asthma. The German was also granted a diabetes medication license by the corporation.

Company Name	Glenmark Pharmaceutical Limited
Market Cap	₹40,125 Crore
Face Value	₹1
Book Value	₹817
P/B	1.85
52 Week High	₹1450
52 Week Low	₹705
DIV. YIELD	0.25%

Financial Data Analysis

To comprehend its performance, we need to look at the company’s PE ratio, return on equity, current ratio, and return on assets. These characteristics will be covered in the following section. These ratios likewise influence Adani Power target share price.

PE Ratio	Return On Assets (ROA)	Current Ratio	Return On Equity (ROE)
8	21%	1.2	6.25%

Glenmark Share Price Target 2024

The Glenmark Pharmaceutical Company is built to serve compounds with small, high, medium, and large volumes. North America, Europe, Japan, Latin America, India, and the rest of the globe are the company’s six global markets. In key markets, the business has 436 DMFs and CEPs. The company is currently developing 26 items, of which 2 are iron complexes and the remaining 7 are cancer-related drugs.

Year	Glenmark Share Price Target 2024
1st Price Target	1,285
2nd Price Target	1,695

Glenmark Share Price Target 2025

The Glenmark Pharmaceutical Company operates in over 80 nations. The corporation has four research and development centers and five production facilities that have received FDA approval. The locations of the R&D centers are Lausanne, Taloja, Mahape, and Sinnar. The organization also finds centers for respiratory therapy, oncology, and dermatology. The company’s annual global revenue is ₹11,850 crore.

Year	Glenmark Share Price Target 2025
1st Price Target	1,735
2nd Price Target	1,955

Glenmark Share Price Target 2027

The company produces a variety of goods, including medicated shampoo (Scalpe Plus), which is used to treat scale flaking and itching, dusting powders such as Candid, which are used to treat yeast infections and fungus, and Ascoril Cough Syrup, which is used to treat runny noses and throat irritation. This corporation is home to a number of brands, including Fintop, Sibet, Glucar, Onabet, Zinox, Glinate, Palnox, Bortrac, and Vorth-XT. The company was placed 50th for generics and biosimilars and 80th out of 100 top biopharmaceuticals companies in the world.

Year	Glenmark Share Price Target 2027
1st Price Target	2,335
2nd Price Target	2,660

Glenmark Share Price Target 2030

The Glenmarkh Company is spread throughout more than 50 countries with 10 manufacturing sites and 50 local offices. Approximately 1400 of the company’s over 15,000 global workers are affiliated with the research and development division. Three oncology compounds with a focus on myeloma, acute myeloid leukemia, and solid tumors were brought together to form Ichnos Glenmark Innovation in 2024 by the Glenmark corporation and its subsidiaries Ichnos Sciences Inc.

Year	Glenmark Share Price Target 2030
1st Price Target	3,335
2nd Price Target	3,700

Glenmark Share Price Target 2040

The quality of Glenmark Pharmaceutical Company’s products is always its top priority. Under the brand name FabiFlu, the business introduced a potent medication called “Favipiravir” in 2020 during the COVID-19 pandemic. With the introduction of the anti-diabetic medication Liraglutide in 2024, the business ventured into the field of injectable anti-diabetic therapy. Additionally, the business signed an exclusive licensing contract with Australia for Ryaltris, a nasal spray.

Year	Glenmark Share Price Target 2040
1st Price Target	7,435
2nd Price Target	7,800

Glenmark Share Price Target 2050

Forecasting the share price of Glenmark in 2050 is somewhat speculative. Trends in the energy market, business success, the state of the economy, and regulatory changes are all important factors to take into account. Consult financial analysts and keep abreast of market changes for a better-informed perspective.

Year	Glenmark Share Price Target 2050
1st Price Target	14,350
2nd Price Target	15,600

Advantages and Disadvantages Of Glenmark

Every share offers various benefits as well as drawbacks. Thus, the following list of benefits and drawbacks equally applies to the Glenmark Share Price Target.

Advantages

• With an efficient cash conversation cycle of -77.75 days, the company performs well.
• The company manages its cash flow well; its PAT is 1.05 percent.
• The company’s interest cover ratio of 8.61 indicates that it has a very good ratio and has very little debt.
• The company’s FII investment share rose to 20.99%.

Disadvantages

• Over the past three years, the company’s net profit growth has declined by 3.58%.
• Over the last three years, the company’s revenue growth has dropped to 6.99%.
• Over the past two years, the company’s ROA percentage has declined.
• The quantity of the company’s net cash flow dropped.

FAQs

Conclusion

We hope https://pricepredictionhub.com/ will provide you with some fundamental knowledge on the Glenmark Share Price Target. We make sure that, over time, the Glenmark Share Price Target may rise to an extremely high position by conducting the necessary research and consulting with specialists. Glenmark is mostly associated with hydropower. Thus, as the need for this industry grows, so does the share’s potential for future profit.

You are welcome to share this website if you believe it will be useful to you. Please use the comment box to ask any questions you may have, and we will do our best to address them and find a solution. We appreciate you coming to our website and staying with us.

Disclaimer

The above-mentioned Glenmark share price targets are for reference purposes only and are not assured to remain accurate. They are dependent upon favorable market circumstances, company performance, and other variables. They are predicated on the assumption of a favorable market. Always conduct your research and consult with a financial advisor before making investment decisions. Past performance does not always guarantee future results.